BioSight
Companies
Abivax S.A. logo

ABVX

NASDAQPARIS
Abivax S.A.
$117.38+1548.60%1Y
ABVX · daily close · illustrative · 0 catalysts marked
$0.00$40$80$119$159Apr '25Aug '25Dec '25Apr '26
1Y high$145.311Y low$5.67range$139.64(2463%)past catalysts

Pipeline3

Phase 2Carcinoma, Hepatocellular
small-molecule
Phase 2Ulcerative Colitis
small-molecule
Phase 2Moderately to Severely Active Crohn Disease
small-molecule

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar